Approach to the management of incidental venous thromboembolic events in patients with cancer

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 12, Issue 11, 2014, Pages 1557-1560

  O'Connell, Casey L ^a   Liebman, Howard A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; WARFARIN; ANTICOAGULANT AGENT;

ANTICOAGULATION; ARTICLE; CANCER PATIENT; CANCER STAGING; DEEP VEIN THROMBOSIS; HUMAN; LUNG EMBOLISM; MULTIDETECTOR COMPUTED TOMOGRAPHY; PREVALENCE; VENOUS THROMBOEMBOLISM; CASE CONTROL STUDY; DISEASE MANAGEMENT; NEOPLASMS; PULMONARY EMBOLISM; RETROSPECTIVE STUDY; VENOUS THROMBOSIS;

ANTICOAGULANTS; CASE-CONTROL STUDIES; DISEASE MANAGEMENT; HUMANS; NEOPLASMS; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84908551228     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2014.0155     Document Type: Article

References (32)

1. Levitan N, Dowlati A, Remick SC, et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine 1999; 78: 285-291.
2. Heit JA. Cancer and venous thromboembolism: scope of the problem. Cancer Control 2005; 12(Suppl 1): 5-10.
3. Stein PD, Beemath A, Meyers FA, et al. Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med 2006; 119: 60-68.
4. Blom JW, Vanderschoot JP, Oostindier MJ, et al. Incidence of venous thrombosis in a large cohort of 66, 329 cancer patients: results of a record linkage study. J Thromb Haemost 2006; 4: 529-535.
5. Prandoni P, Lensing AW, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002; 100: 3484-3488.
6. Hutten BA, Prins MH, Gent M, et al. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol 2000; 18: 3078-3083.
7. Khorana AA, Francis CW, Culakova E, et al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 2007; 5: 632-634.
8. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(Suppl 2): e419S-494S.
9. Lyman GH, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 2013; 31: 2189-2204.
10. Farge D, Debourdeau P, Beckers M, et al. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost 2013; 11: 56-70.
11. Streiff MB, Bockenstedt PL, Cataland SR, et al. Venous thromboembolic disease. J Natl Compr Canc Netw 2011; 9: 714-777.
12. Khorana AA, O'Connell C, Agnelli G, et al. Incidental venous thromboembolism in oncology patients. Subcommittee on Hemostasis and Malignancy of the SSC of the ISTH. J Thromb Haemost 2012; 10: 2602-2604.
13. Dentali F, Ageno W, Becattini C, et al. Prevalence and clinical history of incidental, asymptomatic pulmonary embolism: a meta-analysis. Thromb Res 2010; 125: 518-522.
14. Ageno W, Squizzato A, Togna A, et al. Incidental diagnosis of a deep vein thrombosis in consecutive patients undergoing a computed tomography scan of the abdomen: a retrospective cohort study. J Thromb Haemost 2012; 10: 158-160.
15. Douma RA, Kok MG, Verberne LM, et al. Incidental venous thromboembolism in cancer patients: prevalence and consequence. Thromb Res 2010; 125: e306-309.
16. Singh R, Sousou T, Mohile S, Khorana A. High rates of symptomatic and incidental thromboembolic events in gastrointestinal cancer patients. J Thromb Haemost 2010; 8: 1879-1881.
17. Moore RA, Adel N, Riedel E, et al. High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis. J Clin Oncol 2011; 29: 3466-3473.
18. Palla A, Rossi g, Falaschi F, et al. Is incidentally detected pulmonary embolism in cancer patients less severe? A case-control study. Cancer Invest 2012; 30: 131-134.
19. O'Connell CL, Boswell WD, Duddalwar V, et al. Unsuspected pulmonary emboli in cancer patients: clinical correlates and relevance. J Clin Oncol 2006; 24: 4928-4932.
20. Abdel-Razeq HN, Mansour AH, Ismael YM. Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome-a comprehensive cancer center experience. Vasc Health Risk Manag 2011; 7: 153-158.
21. O'Connell C, Razavi P, Ghalichi M, et al. Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging MDCT scanning. J Thromb Haemost 2011; 9: 305-311.
22. Dentali F, Ageno W, Pierfranceschi MG, et al. Prognostic relevance of an asymptomatic venous thromboembolism in patients with cancer. J Thromb Haemost 2011; 9: 1081-1083.
23. den Exter PL, Hooijer J, Dekkers OM, et al. Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. J Clin Oncol 2011; 29: 2405-2409.
24. O'Connell C, Razavi P, Liebman H. Symptoms adversely impact survival among patients with cancer and unsuspected pulmonary embolism. J Clin Oncol 2011; 29: 4208-4209.
25. Grigoropoulos NF, Shaw AS, Hampson FA, et al. Incidental pulmonary emboli in lymphoma patients are associated with aggressive disease and poor prognosis. J Thromb Haemost 2010; 8: 2835-2836.
26. Sun JM, Kim TS, Lee J, et al. Unsuspected pulmonary emboli in lung cancer patients: the impact on survival and the significance of anticoagulation therapy. Lung Cancer 2010; 69: 330-336.
27. Franklin JM, Rahman N, Gleeson FV. The clinician's response to a report of an incidental pulmonary embolism detected on multidetector CT. Postgrad Med J 2011; 87: 746-749.
28. Lee AY, Levine MN, Baker RI, et al. Low-molecular heparin versus a coumarin for prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; 349: 46-53
29. Carrier M, Righini M, Wells PS, et al. Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies. J Thromb Haemost 2010; 8: 1716-1722.
30. Donato AA, Khoche S, Santora J, Wagner B. Clinical outcomes in patients with isolated subsegmental pulmonary emboli diagnosed by multidetector CT pulmonary angiography. Thromb Res 2010; 126: e266-270.
31. Eyer BA, Goodman LR, Washington L. Clinicians' response to radiologists' reports of isolated subsegmental pulmonary embolism or inconclusive interpretation of pulmonary embolism using MDCT. Am J Roentgenol 2005; 184: 623-628.
32. Carrier M, Kimpton M, Le Gal G, et al. The management of a sub-segmental pulmonary embolism: a cross-sectional survey of Canadian thrombosis physicians. J Thromb Haemost 2011; 9: 1412-1415.